Gilead Sciences' TROP2-targeting drug Trodelvy is already used as a third-line treatment for PD-L1-positive triple-negative breast cancer (TNBC), but could be heading for use in previously untreated ...
A lot will be on the line Thursday night in New Jersey when the Pittsburgh Penguins take on the Devils. Plus, Alex Ovechkin might or might not retire, Konnor Griffin is must-see TV, and there’s local ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results